Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler

Study Title
A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
Teva Identifier
ABS-AS-306
ClinicalTrials.gov Identifier
NCT01218009
Study Status
Terminated
Trial Condition(s)
Asthma
Interventions
Drug: Placebo Spiromax | Drug: Albuterol Spiromax

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
10/01/2010 - 12/01/2010
Phase
Phase 3

Study Type

Interventional